FHIR IG analytics| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113883.3.3157.1023.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.3157.1023/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1023 |
| Version | 20200716 |
| Status | active |
| Date | 2020-07-16T01:00:25-04:00 |
| Name | LiverLesionMassOrNeoplasm |
| Title | Liver Lesion (Mass or Neoplasm) |
| Realm | us |
| Authority | hl7 |
| Description | This value set is used to calculate OP-10 (Abdomen Computed Tomography (CT)—Use of Contrast Material), a claims-based measure used in the Centers for Medicare & Medicaid Services' Hospital Outpatient Quality Reporting (HOQR) Program. In calculation of OP-10, diagnoses of liver lesion (mass or neoplasm) must appear on the abdomen CT claim to be excluded from the measure’s initial patient population. |
| Purpose | (Clinical Focus: This set of values contains ICD-10 codes associated with secondary malignant neoplasm of the liver and intrahepatic bile duct.),(Data Element Scope: The intent of the data is to identify patients with a secondary malignant neoplasm of the liver and intrahepatic bile duct.),(Inclusion Criteria: ICD-10 codes associated with secondary malignant neoplasm of the liver and intrahepatic bile duct are included in this value set.),(Exclusion Criteria: Primary malignant neoplasms of the liver and intrahepatic bile duct and malignant neoplasms that are not associated with the liver, or those captured in systems other than ICD-10, are excluded from the value set.) |
No resources found
| CodeSystem | |
| icd-10-cm | International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) |
No narrative content found in resource
FHIR
FHIRsmith{
"resourceType": "ValueSet",
"id": "2.16.840.1.113883.3.3157.1023",
"meta": {
"versionId": "10",
"lastUpdated": "2024-12-02T15:58:57.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "Acumen OP Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2024-04-22"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2020-07-16"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1023",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113883.3.3157.1023"
}
],
"version": "20200716",
"name": "LiverLesionMassOrNeoplasm",
"title": "Liver Lesion (Mass or Neoplasm)",
"status": "active",
"experimental": false,
"date": "2020-07-16T01:00:25-04:00",
"publisher": "Acumen OP Steward",
"description": "This value set is used to calculate OP-10 (Abdomen Computed Tomography (CT)—Use of Contrast Material), a claims-based measure used in the Centers for Medicare & Medicaid Services' Hospital Outpatient Quality Reporting (HOQR) Program. In calculation of OP-10, diagnoses of liver lesion (mass or neoplasm) must appear on the abdomen CT claim to be excluded from the measure’s initial patient population.",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: This set of values contains ICD-10 codes associated with secondary malignant neoplasm of the liver and intrahepatic bile duct.),(Data Element Scope: The intent of the data is to identify patients with a secondary malignant neoplasm of the liver and intrahepatic bile duct.),(Inclusion Criteria: ICD-10 codes associated with secondary malignant neoplasm of the liver and intrahepatic bile duct are included in this value set.),(Exclusion Criteria: Primary malignant neoplasms of the liver and intrahepatic bile duct and malignant neoplasms that are not associated with the liver, or those captured in systems other than ICD-10, are excluded from the value set.)",
"compose": {
"include": [
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"concept": [
{
"code": "C22.0",
"display": "Liver cell carcinoma"
},
{
"code": "C22.1",
"display": "Intrahepatic bile duct carcinoma"
},
{
"code": "C22.2",
"display": "Hepatoblastoma"
},
{
"code": "C22.3",
"display": "Angiosarcoma of liver"
},
{
"code": "C22.4",
"display": "Other sarcomas of liver"
},
{
"code": "C22.7",
"display": "Other specified carcinomas of liver"
},
{
"code": "C22.8",
"display": "Malignant neoplasm of liver, primary, unspecified as to type"
},
{
"code": "C22.9",
"display": "Malignant neoplasm of liver, not specified as primary or secondary"
},
{
"code": "C78.7",
"display": "Secondary malignant neoplasm of liver and intrahepatic bile duct"
},
{
"code": "C7B.02",
"display": "Secondary carcinoid tumors of liver"
},
{
"code": "D01.5",
"display": "Carcinoma in situ of liver, gallbladder and bile ducts"
},
{
"code": "D13.4",
"display": "Benign neoplasm of liver"
},
{
"code": "D13.5",
"display": "Benign neoplasm of extrahepatic bile ducts"
},
{
"code": "D37.6",
"display": "Neoplasm of uncertain behavior of liver, gallbladder and bile ducts"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:583be6d2-e3a8-44ef-b6c4-69718d123e6b",
"timestamp": "2025-05-23T21:58:32-04:00",
"total": 14,
"contains": [
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "C22.0",
"display": "Liver cell carcinoma"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "C22.1",
"display": "Intrahepatic bile duct carcinoma"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "C22.2",
"display": "Hepatoblastoma"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "C22.3",
"display": "Angiosarcoma of liver"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "C22.4",
"display": "Other sarcomas of liver"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "C22.7",
"display": "Other specified carcinomas of liver"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "C22.8",
"display": "Malignant neoplasm of liver, primary, unspecified as to type"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "C22.9",
"display": "Malignant neoplasm of liver, not specified as primary or secondary"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "C78.7",
"display": "Secondary malignant neoplasm of liver and intrahepatic bile duct"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "C7B.02",
"display": "Secondary carcinoid tumors of liver"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D01.5",
"display": "Carcinoma in situ of liver, gallbladder and bile ducts"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D13.4",
"display": "Benign neoplasm of liver"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D13.5",
"display": "Benign neoplasm of extrahepatic bile ducts"
},
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "D37.6",
"display": "Neoplasm of uncertain behavior of liver, gallbladder and bile ducts"
}
]
}
}